USD 0.0
(-0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2022 | 3.36 Million USD | 195.94% |
2021 | 1.13 Million USD | -32.33% |
2020 | 1.68 Million USD | -17.47% |
2019 | 2.03 Million USD | 20.14% |
2018 | 1.69 Million USD | -98.12% |
2017 | 89.98 Million USD | -25.21% |
2016 | 120.3 Million USD | -9.3% |
2015 | 132.64 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q2 | 3.36 Million USD | 123.5% |
2022 Q4 | 1.5 Million USD | 0.0% |
2021 Q2 | 1.68 Million USD | 23.99% |
2021 Q4 | 1.02 Million USD | -38.9% |
2020 Q4 | 1.35 Million USD | -33.43% |
2020 Q2 | 2.03 Million USD | -30.82% |
2019 Q2 | 1.69 Million USD | 0.0% |
2019 Q4 | 2.94 Million USD | 73.65% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Borqs Technologies, Inc. | 35.86 Million USD | 90.617% |
Ever-Glory International Group, Inc. | 208.34 Million USD | 98.385% |
LianBio | 36.76 Million USD | 90.847% |
SVB Financial Group | 195.49 Billion USD | 99.998% |